How long is the Skyla (levonorgestrel) IUD effective?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Skyla IUD Duration of Effectiveness

The Skyla levonorgestrel IUD (13.5 mg) is FDA-approved and effective for 3 years of contraceptive use. 1, 2

Approved Duration

  • Skyla is specifically approved for 3 years of use, distinguishing it from higher-dose levonorgestrel IUDs like Mirena (52 mg), which is approved for 5 years but effective up to 7 years. 1, 2

  • The 3-year approval reflects the lower levonorgestrel dose (13.5 mg) compared to the 52 mg formulations, which release approximately 14 mcg of levonorgestrel per 24 hours. 3

No Evidence for Extended Use

  • Unlike the Mirena IUD, there is no published data supporting extended use of Skyla beyond its 3-year approval period. 4

  • A comprehensive literature review on extended IUD use explicitly states: "We found no data to support use of the LNG-IUS 13.5 mg (Skyla) beyond 3 years." 4

Contraceptive Efficacy

  • Skyla maintains a failure rate of less than 1% throughout its approved 3-year duration, making it highly effective for contraception. 1

  • The device works primarily by thickening cervical mucus and inhibiting sperm motility, with all mechanisms occurring before fertilization. 2

Clinical Implications

  • The device should be removed and replaced at 3 years if continued contraception is desired, as there is no safety or efficacy data beyond this timeframe. 1, 4

  • For patients seeking longer-duration contraception without device replacement, consider the 52 mg levonorgestrel IUDs (Mirena or Liletta) or the copper IUD (ParaGard), which are approved for 5-10 years respectively. 1

Common Pitfall to Avoid

  • Do not extrapolate extended-use data from Mirena to Skyla—the lower hormone dose and different release kinetics mean Skyla's efficacy beyond 3 years remains unknown and should not be assumed. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Levonorgestrel Intrauterine Device (IUD) Contraception and Therapeutic Benefits

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intrauterine devices: an update.

American family physician, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.